XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.3
Unaudited Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
ATM Program
Consolidated Subsidiary
Vendor
Total Stockholders’ Deficit Attributable to the Company
Total Stockholders’ Deficit Attributable to the Company
ATM Program
Total Stockholders’ Deficit Attributable to the Company
Consolidated Subsidiary
Total Stockholders’ Deficit Attributable to the Company
Vendor
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
ATM Program
[1]
Common Stock
Class A Common Stock
Consolidated Subsidiary
[1]
Common Stock
Class A Common Stock
Vendor
[1]
Common Stock
Class B Common Stock
[1]
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Additional 
Paid-in 
Capital
Additional 
Paid-in 
Capital
ATM Program
Additional 
Paid-in 
Capital
Consolidated Subsidiary
Additional 
Paid-in 
Capital
Vendor
Accumulated 
Other 
Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024                 439,461 [1]       45 0                
Beginning balance at Dec. 31, 2024 $ 114,967       $ 114,967       $ 0 [1]       $ 0 $ 0   $ 4,421,569       $ 7,744 $ (4,314,346) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)                 573,521 [1]         (3,983,897)                
Conversion of notes payable and accrued interest into Class A Common Stock 145,275       145,275                     145,275            
Issuance of Stock 1       1                     1            
Reclassification of SPA warrants from liability to equity (in shares)                           14,720,914                
Settlement of HSL s.r.l. lawsuit with issuance of Class A Common Stock (in shares) [1]                 10,607                          
Settlement of HSL s.r.l. lawsuit with issuance of Class A Common Stock 2,245       2,245                     2,245            
Related party debt restructuring 3,767       3,767                     3,767            
Stock-based compensation 536       536                     536            
Exercise of warrants (in shares) [1]                 50,107                          
Exercise of warrants 14,090       14,090                     14,090            
Noncontrolling interest 38,204                                         38,204
Issuance of shares for RSU vesting net of tax withholdings (in shares) [1]                 1,674                          
Issuance of shares for RSU vesting net of tax withholdings 74       74                     74            
Foreign currency translation adjustment (1,558)       (1,558)                             (1,558)    
Net loss (357,141)       (357,141)                               (357,141)  
Ending balance (in shares) at Sep. 30, 2025                 1,075,370 [1]       45 10,737,017                
Ending balance at Sep. 30, 2025 (39,540)       (77,744)       $ 0 [1]       $ 0 $ 0   4,587,557       6,186 (4,671,487) 38,204
Beginning balance (in shares) at Jun. 30, 2025                 818,148 [1]       45 4,400,232                
Beginning balance at Jun. 30, 2025 59,856       59,856       $ 0 [1]       $ 0 $ 0   4,502,001       7,155 (4,449,300) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)                 206,306 [1]         (2,031,268)                
Conversion of notes payable and accrued interest into Class A Common Stock 68,285       68,285                     68,285            
Issuance of Stock (in shares)                           8,368,053                
Issuance of Stock 1       1                     1            
Related party debt restructuring 3,113       3,113                     3,113            
Stock-based compensation 67       67                     67            
Exercise of warrants (in shares) [1]                 50,107                          
Exercise of warrants 14,090       14,090                     14,090            
Noncontrolling interest 38,204                                         38,204
Issuance of shares for RSU vesting net of tax withholdings (in shares) [1]                 809                          
Foreign currency translation adjustment (969)       (969)                             (969)    
Net loss (222,187)       (222,187)                               (222,187)  
Ending balance (in shares) at Sep. 30, 2025                 1,075,370 [1]       45 10,737,017                
Ending balance at Sep. 30, 2025 (39,540)       (77,744)       $ 0 [1]       $ 0 $ 0   4,587,557       6,186 (4,671,487) 38,204
Beginning balance (in shares) at Dec. 31, 2025                 1,327,538 [1]       45 7,184,760 0              
Beginning balance at Dec. 31, 2025 7,759       (27,338)       $ 0 [1]       $ 0 $ 0 $ 0 4,673,887       3,817 (4,705,042) 35,097
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)                 4,477,001 [1]         2,934,108                
Conversion of notes payable and accrued interest into Class A Common Stock 69,911       69,911                     69,911            
Issuance of Stock (in shares)                   3,116,131 12,821 10,042   89,751 11,502              
Issuance of Stock 11,502 $ 6,215 $ 500 $ 1,210 11,502 $ 6,215 $ 500 $ 1,210               11,502 $ 6,215 $ 500 $ 1,210      
Elimination of Class A Common Stock and Series C Preferred Stock held for a consolidated subsidiary (in shares) [1]                 (12,821)                          
Elimination of Class A Common Stock and Series C Preferred Stock held for a consolidated subsidiary (500)       (500)                     (500)            
Elimination of Series C Preferred Stock held for the benefit of a consolidated subsidiary (in shares)                             (11,502)              
Elimination of Series C Preferred Stock held for the benefit of a consolidated subsidiary (11,502)       (11,502)                     (11,502)            
Vendor settlement adjustment 130       130                     130            
Non-cash advisory expense 2,001       2,001                     2,001            
Release Chongqing accrued interest and penalties 20,196       20,196                     20,196            
Issuance of equity-classified warrants 2       2                     2            
Cancellation of warrants and derivative call options 4,316       4,316                     4,316            
Reverse stock split round-up and registrar balance adjustments (in shares) [1]                 199,889                          
Stock-based compensation 279       279                     279            
Issuance of shares for RSU vesting net of tax withholdings (in shares) [1]                 333,093                          
Issuance of shares for RSU vesting net of tax withholdings 1,362       1,362                     1,362            
Reclassification of stock-based compensation liabilities to equity (in shares) 1,578       1,578                     1,578            
Issuance of subsidiary common stock under ELOC 15       15                     15            
Foreign currency translation adjustment (4,033)       (4,033)                             (4,033)    
Net loss (91,061)       (83,431)                               (83,431) (7,630)
Ending balance (in shares) at Sep. 30, 2026                 9,463,694 [1]       45 4,340,403 0              
Ending balance at Sep. 30, 2026 19,880       (7,587)       $ 0 [1]       $ 0 $ 0 $ 0 4,781,102       (216) (4,788,473) 27,467
Beginning balance (in shares) at Jun. 30, 2026                 2,388,454 [1]       45 4,948,854 0              
Beginning balance at Jun. 30, 2026 1,412       (27,290)       $ 0 [1]       $ 0 $ 0 $ 0 4,751,694       943 (4,779,927) 28,702
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)                 3,429,068 [1]         (698,202)                
Conversion of notes payable and accrued interest into Class A Common Stock 13,677       13,677                     13,677            
Issuance of Stock (in shares)                   3,116,131       89,751                
Issuance of Stock   $ 6,215       $ 6,215                     $ 6,215          
Vendor settlement adjustment 130       130                     130            
Non-cash advisory expense 2,001       2,001                     2,001            
Issuance of equity-classified warrants 2       2                     2            
Cancellation of warrants and derivative call options 4,316       4,316                     4,316            
Reverse stock split round-up and registrar balance adjustments (in shares) [1]                 199,889                          
Stock-based compensation 246       246                     246            
Issuance of shares for RSU vesting net of tax withholdings (in shares) [1]                 330,152                          
Issuance of shares for RSU vesting net of tax withholdings 1,228       1,228                     1,228            
Reclassification of stock-based compensation liabilities to equity (in shares) 1,578       1,578                     1,578            
Issuance of subsidiary common stock under ELOC 15       15                     15            
Foreign currency translation adjustment (1,159)       (1,159)                             (1,159)    
Net loss (9,781)       (8,546)                               (8,546) (1,235)
Ending balance (in shares) at Sep. 30, 2026                 9,463,694 [1]       45 4,340,403 0              
Ending balance at Sep. 30, 2026 $ 19,880       $ (7,587)       $ 0 [1]       $ 0 $ 0 $ 0 $ 4,781,102       $ (216) $ (4,788,473) $ 27,467
[1] Retrospectively adjusted for the effect of the Reverse Stock Split effected on July 24, 2026.